The largest database of trusted experimental protocols

Cd4 t cell negative selection kit

Manufactured by Miltenyi Biotec
Sourced in Germany, United States

The CD4+ T cell negative selection kit is a laboratory tool designed for the isolation of CD4+ T cells from a mixed cell population. The kit utilizes an antibody-based approach to selectively deplete non-CD4+ T cells, enabling the enrichment of the desired CD4+ T cell population.

Automatically generated - may contain errors

10 protocols using cd4 t cell negative selection kit

1

OTII T Cell Polarization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naive TCRβ+CD4+vβ5+Thy1.1(Foxp3)CD44loCD62Lhi OTII T cells were sort purified after enrichment with a CD4+ T cell negative selection kit (Miltenyi Biotec). DC subsets were sort purified after enrichment with Dynabeads Mouse DC Enrichment Kit (Invitrogen). DCs and T cells were co-cultured in triplicate at a ratio of 2 × 104 DCs to 1 × 105 T cells in the presence of OVA323–339 (1 μg/ml; Invivogen), under Th0 conditions (anti-IL-4 (11B11) and anti-IFN-γ (XMG1.2)) or with the addition of polarizing cytokines (Th1: 10 ng/ml IL-12 (R&D systems) and anti-IL-4; Th2: 10 ng/ml IL-4 (Peprotech), anti-IL-12 (C17.8), and anti-IFN-γ; Th17: 2ng/ml TGF-β1 (R&D systems), 20 ng/ml IL-6 (Peprotech), 10 ng/ml IL-1β, anti-IL-4, and anti-IFN-γ; iTreg: 2ng/ml TGF-β1, 500IU/ml of IL-2 (Peprotech). IL-2 (50IU/ml) was added to Th0, Th1, and iTreg conditions on d3. All blocking antibodies were at 10 μg/ml. Cytokine production or Foxp3 expression was assessed after 4 days of culture.
+ Open protocol
+ Expand
2

Isolation and Activation of Antigen-Specific CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ten 8- to 12-week-old HLA-A2.1-/HLA-DR1-transgenic female mice (HLA-DRB1*01:01) were intravenously injected with 2 × 105 EL4 mouse thymoma cells expressing human CD20 (EL4-huCD20) [25 (link)]. Splenic CD4+ T cells from these immunized mice were isolated 21 days after injection using the CD4+ T cell negative selection kit (Miltenyi Biotec) and pooled. The purified pooled CD4+ T cells (105 cells/well) were then incubated in ELISPOT plates for 36 h with 104 HLA-DRB1*01:01-expressing artificial antigen-presenting cells (AAPCs) derived from NIH-3T3 cells [26 (link)] which were loaded with the CD20-derived peptide mixture.
+ Open protocol
+ Expand
3

Isolation and Culture of CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mononuclear cells (PBMCs) were isolated from peripheral blood by Ficoll density centrifugation (Cat# 45-001-750, GE Healthcare, Piscataway, NJ). CD4 T cells were isolated from PBMCs using the CD4 T cell negative selection kit (Cat# 130-096-533, Miltenyi Biotec, Auburn, CA). The cells were cultured in RPMI-1640 medium supplemented with 10% FBS (Cat# S11050H, Atlanta Biologicals, Flowery Branch, GA), 100 IU/ml penicillin, and 2 mM L-glutamine (Cat# 25-030-081, Thermo Fisher Scientific, Waltham, MA) and maintained at 37°C in 5% CO2 incubator.
+ Open protocol
+ Expand
4

Isolation and Activation of CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated from whole blood of HS and PLHIV using Ficoll-Paque solution (GE Healthcare; Piscataway, NJ) and density gradient centrifugation separation. CD4 T cells were purified from PBMCs using CD4 T cell negative selection kit (Miltenyi Biotec; Auburn, CA). The cells were cultured for 24 h in RPMI-1640 media (Fisher Scientific; Pittsburgh, PA) supplemented with 10% heat-inactivated fetal bovine serum (Atlanta Biologicals; Flowery Branch, GA), 100 IU/ml penicillin, and 2 mM L-glutamine (Thermo Scientific; Logan, Utah) at 37°C and 5% CO2 atmosphere. For TCR stimulation, CD4 T cells were cultured in media containing Dynabeads coated with human T-activator CD3/CD28 (Fisher Scientific). For knockdown and overexpression experiments, the cells were stimulated with soluble CD3/CD28 (BD biosciences; San Jose, CA) and recombinant human IL-2 (PeproTech; Rocky Hill, NJ) for 2 days prior to lentivirus infections and for another 3 days post transfection. For anti-PD-1 treatment and IL-2 administration experiment, CD4 T cells isolated from HS were cultured for 24 h in the presence of Dynabeads coated with human T cell activator anti-CD3/CD28, anti-PD-1 (nivolumab, 20 μg/ml; Selleckchem, TX), human IgG4 isotype control antibody antibodies (Biolegend), or IL-2 (100 units/ml; Biolegend).
+ Open protocol
+ Expand
5

Regulation of T Cell Apoptosis and DNA Damage

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood by Ficoll density centrifugation (GE Healthcare, Piscataway, NJ). CD4+ T cells were isolated from PBMCs using the CD4+ T Cell Negative Selection Kit (Miltenyi Biotec Inc., Auburn, CA). T cells were cultured in RPMI 1640 medium containing 10% FBS (Atlanta Biologicals, Flowery Branch, GA), 100 IU/ml penicillin, and 2 mM L-glutamine (Thermo Scientific, Logan, Utah) at 37°C and 5% CO2 atmosphere. Cells were harvested after day 1 or day 4 of culture for the detection of apoptosis and DNA damage. To test the role of ATM activation in repairing DNA damage and apoptosis, 10 μM ATM inhibitor (KU60019, Abcam, Cambridge, MA) or DMSO were added to the cultures at day 1, and the cells were collected after 48 h for measuring apoptosis and DNA damage. To determine the role of the PI3K pathway in ATM activation, purified CD4 T cells were cultured for 48 h in the presence or absence of 20 μM PI3K inhibitor (LY294002, Sigma), followed by flow cytometry or western blot analysis.
+ Open protocol
+ Expand
6

Isolation and Activation of Primary Human T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs from healthy donors samples were isolated using Ficoll-Hypaque gradient centrifugation. T cells were obtained using SepMate™ PBMC Isolation Tube (STEMCELL, Vancouver, Canada). Isolated T lymphocytes were maintained in RPMI 1640 or ImmunoCult™-XF T cell Expansion Media (STEMCELL, Vancouver, Canada) with 50 U/ml interleukin-2 (PeproTech, Cranbury, NJ, USA). CD3+ T cells, CD4+ T cells, and CD8+ T cells were isolated using Pan T negative selection kit (Miltenyi Biotec, North Rhine-Westphalia, Germany), CD4+ T cell negative selection kit (Miltenyi Biotec, North Rhine-Westphalia, Germany) and CD8+ T-cell negative selection kit (Miltenyi Biotec, North Rhine-Westphalia, Germany), respectively, following the manufacturer’s instructions. Isolated T cells were activated by adding a CD3/28 T-cell activator (STEMCELL, Vancouver, Canada) and 50 U/ml interleukin-2. T cells were resuspended in CryoStor CS10(STEMCELL, Vancouver, Canada) at -80°C and thawed quickly in a 37°C water bath. All cells were grown in a humidified incubator at 37°C supplied with 5% CO2 and tested regularly for Mycoplasma contamination.
+ Open protocol
+ Expand
7

Naive CD4+ vβ10+ T Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naive CD4+vβ10+CD25CD44loCD62Lhi C7 T cells were sort purified after enrichment with a CD4+ T cell negative selection kit (Miltenyi Biotec). Dendritic and Thetis cell subsets were sort purified from RorcVenus-creERT2 mice using gating strategy above with inclusion of CCR6 to distinguish TC I and TC II from TC III and TC IV. cDC2s were distinguished from their CCR7+ counterparts by CD11chiMHCIIint expression. T cells were co-cultured in triplicate at a ratio of 300 dendritic or Thetis cells to 1 × 103 T cells in the presence of ESAT peptide (1 µg ml−1; Invivogen), with the addition of 0.5 ng ml−1 TGFβ1 (Peprotech), 100 IU ml−1 of IL-2 (NCI). FOXP3 expression was assessed after 4 days of culture.
+ Open protocol
+ Expand
8

Chromatin Immunoprecipitation of Foxo1

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells from C57BL/6 mice were purified by a CD4+ T cell negative selection kit (Miltenyi Biotech) and were activated by plate-bound anti-CD3 and anti-CD28 (2 μg/ml each) under either neutral condition (TH0) for 2 days. Cells were rested for additional 3 days and were restimulated with plate-bound anti-CD3 and anti-CD28 (0.1 μg/ml) for 24 hours before they were subjected to chromatin preparation for the ChIP analysis. Chromatin fraction preparation and ChIP were performed using the SimpleChIP Enzymatic Chromatin IP Kit (Cell Signaling Technology). Antibody against Foxo1 was purchased from Santa Cruz Biotechnology.
+ Open protocol
+ Expand
9

Adoptive Transfer of ILCs and CD4 T-Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 mice (Taconic) were treated for 4 weeks with AMNV (see above) or control water, and then used as donors for the transfers. Lungs and small intestines were digested as outlined above (lungs were put directly into the same digest buffer as the intestines, after finely mincing), then stained with anti-CD45, anti-CD90.2, anti-CD127 and lineage markers (CD3, CD19, CD11b). Isolated leukocytes from the lung/intestine were pooled and ILCs were FACS-sorted (defined as CD45+CD90.2+CD127+lineage) into sterile sorting buffer (HBSS supplemented with 2 mM EDTA, 10% FCS, 100 U/mL penicillin, 100 μg/mL streptomycin) using a FACS Aria instrument. CD4+ T-cells were isolated from the spleens of donor mice using the Miltenyi CD4+ T-cell negative selection kit, as per the manufacturer’s instructions. Purified ILCs and CD4+ T-cells were combined in sterile PBS at a ratio of 200:1 (T-cells: ILCs) and 100 μL (2×106 CD4 T-cells, 1×104 ILCs) injected intraperitoneally into Rag2−/−Il2rg−/− recipients. The mice were infected with C. albicans approximately 18 hours after the adoptive transfer of CD4 T-cells and ILCs.
+ Open protocol
+ Expand
10

Isolation and Culture of Human CD4 T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated from whole blood using Ficoll density centrifugation (GE Healthcare; Piscataway, NJ, USA). CD4 T cells were isolated from PBMCs using a CD4 T Cell Negative Selection Kit (Miltenyi; Cambridge, MA, USA). CD4 T cells were cultured in RPMI-1640 medium containing 10% fetal bovine serum (FBS) (Atlanta Biologicals, Flowery Branch, GA, USA), 100 IU/mL penicillin, and 2 mM L-glutamine (Thermo Scientific, Logan, UT, USA), and maintained at 37 °C in a 5% CO2 incubator.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!